So back in May I suggested the DEP pipeline and also the partner program slides in the upcoming 2024 Annual Report would look a lot different from last year. Of course @Starlink said I was just spreading misinformation.
Well as it turned out, there wasn’t even a partnered DEP program slide. In fact MSD and Genentech were only mentioned briefly in dispatches. As for DEP-Gemcitabine in the pipeline, seems it has disappeared, crickets ….
Go figure.
So back in May I suggested the DEP pipeline and also the partner...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |